Results 141 to 150 of about 132,339 (311)
A ROS‐responsive biomimetic nanoparticle platform co‐delivers DIDS and Mdivi‐1 to protect mitochondria and promote neural repair after intracerebral hemorrhage. By targeting LPAR1/VDAC1‐related mitochondrial dysfunction, the nanotherapy reduces oxidative injury, neuronal apoptosis, and blood‐brain barrier disruption, improving neurological recovery and
Ling Gao +7 more
wiley +1 more source
Wiwanitkit, Somsri, Wiwanitkit, Viroj
openaire +2 more sources
Bioenergetic-based neuroprotection and glaucoma
Website © 2008 Ingenta. Article copyright remains with the publisher, society or author(s) as specified within the articlePrimary open-angle glaucoma (POAG) is a pressure-sensitive optic neuropathy which results in the death of retinal ganglion cells and
Chidlow, G. +3 more
core +1 more source
Parkinson's disease currently has no disease‐modifying therapies. In Caenorhabditis elegans, Escherichia coli E8 alleviates α‐synuclein‐provoked PD‐related defects through its bioactive metabolite 1‐ALPP, which combats PD by triggering AMPK/mTOR/HLH‐30‐dependent autophagy and suppressing α‐synuclein LLPS‐mediated fibrillization.
Mingqin Qu +12 more
wiley +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
Neuroprotection can be defined as medical prophylactic and therapeutic intervention aimed at neuronal tissue and function. Hardly any concept of neuroprotection has been convincingly efficient in man thus far. Lithium has been used for the treatment of
Elvsåshagen, Torbjørn
core
In the context of ischemic stroke, rescuing neurons can be theoretically achieved with either reperfusion or neuroprotection. Reperfusion works via the rapid restoration of oxygen and glucose delivery.
Tejima-Mandeville, E. +9 more
core +1 more source
Ocular hypertension induces early hyperactivity in inner retinal inhibitory circuitry before substantial retinal ganglion cell loss. Sustained pharmacological inhibition of GABAergic/glycinergic neurotransmission and Vgat‐targeted Lin28 expression suppress this hyperactivity and improve RGC survival without reducing intraocular pressure. These findings
Eunji Hong +7 more
wiley +1 more source
Nutraceuticals in CNS diseases: Potential mechanisms of neuroprotection
In recent years, there has been increasing attention devoted to the possibility that several nutraceuticals may act as neuroprotective agents. Such protective effects have often been ascribed to a direct antioxidant effect; however, the exact mechanisms ...
Garrick J. +7 more
core +1 more source
This study identifies β‐adducin as a regulator of lysosomal integrity in ischemic neurons. Ischemia‐associated FTO loss increases m6A modification and destabilizes Add2 mRNA, reducing β‐adducin expression and promoting PLA2G4A accumulation at lysosomes.
Hui‐qin Li +9 more
wiley +1 more source

